Commentary on: Salivary biomarkers for cancer diagnosis: a meta-analysis
- PMID: 32167392
- PMCID: PMC7877927
- DOI: 10.1080/07853890.2020.1743351
Commentary on: Salivary biomarkers for cancer diagnosis: a meta-analysis
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Comment in
-
Response to commentary by Lu and Wang on "Salivary biomarkers for cancer diagnosis: a meta-analysis".Ann Med. 2020 May-Jun;52(3-4):146. doi: 10.1080/07853890.2020.1746391. Epub 2020 Apr 2. Ann Med. 2020. PMID: 32202950 Free PMC article. No abstract available.
Comment on
-
Salivary biomarkers for cancer diagnosis: a meta-analysis.Ann Med. 2020 May-Jun;52(3-4):131-144. doi: 10.1080/07853890.2020.1730431. Epub 2020 Apr 11. Ann Med. 2020. PMID: 32056455 Free PMC article.
References
-
- Xie ZJ, Chen G, Zhang XC, et al. Saliva supernatant miR-21: a novel potential biomarker for esophageal cancer detection. Asian Pac J Cancer Prev. 2012;13(12):6145–6149. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical